HYDROCODONE

Hydrocodone Adverse Events Reported to the FDA Over Time

How are Hydrocodone adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Hydrocodone, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Hydrocodone is flagged as the suspect drug causing the adverse event.

Most Common Hydrocodone Adverse Events Reported to the FDA

What are the most common Hydrocodone adverse events reported to the FDA?

Completed Suicide	3186 (10.29%)
Cardiac Arrest	1151 (3.72%)
Cardio-respiratory Arrest	1117 (3.61%)
Respiratory Arrest	1111 (3.59%)
Intentional Drug Misuse	685 (2.21%)
Death	588 (1.9%)
Drug Abuse	552 (1.78%)
Drug Toxicity	470 (1.52%)
Multiple Drug Overdose	433 (1.4%)
Nausea	395 (1.28%)
Drug Ineffective	394 (1.27%)
	Show More
Vomiting	327 (1.06%)
Overdose	309 (1%)
Poisoning	300 (.97%)
Somnolence	269 (.87%)
Pain	262 (.85%)
Confusional State	225 (.73%)
Multiple Drug Overdose Intentional	223 (.72%)
Depression	208 (.67%)
Headache	206 (.67%)
Anxiety	194 (.63%)
Constipation	194 (.63%)
Dizziness	185 (.6%)
Fall	184 (.59%)
Medication Error	168 (.54%)
Dyspnoea	160 (.52%)
Insomnia	155 (.5%)
Loss Of Consciousness	149 (.48%)
Hypotension	141 (.46%)
Malaise	141 (.46%)
Hallucination	137 (.44%)
Mental Status Changes	137 (.44%)
Pruritus	132 (.43%)
Drug Interaction	131 (.42%)
Abdominal Pain	127 (.41%)
Drug Abuser	127 (.41%)
Feeling Abnormal	125 (.4%)
Drug Dependence	124 (.4%)
Coma	123 (.4%)
Unresponsive To Stimuli	121 (.39%)
Suicidal Ideation	118 (.38%)
Back Pain	116 (.37%)
Intentional Overdose	110 (.36%)
Diarrhoea	109 (.35%)
Fatigue	107 (.35%)
Aspartate Aminotransferase Increase...	106 (.34%)
Asthenia	105 (.34%)
Drug Screen Positive	103 (.33%)
Drug Hypersensitivity	102 (.33%)
Chest Pain	101 (.33%)
Convulsion	100 (.32%)
Lethargy	100 (.32%)
Pain In Extremity	100 (.32%)
Agitation	97 (.31%)
Heart Rate Increased	95 (.31%)
Alanine Aminotransferase Increased	94 (.3%)
Amnesia	92 (.3%)
Nervousness	90 (.29%)
Accidental Overdose	89 (.29%)
Memory Impairment	89 (.29%)
Pneumonia	89 (.29%)
Incorrect Dose Administered	88 (.28%)
Oedema Peripheral	88 (.28%)
Pulmonary Oedema	88 (.28%)
Depressed Level Of Consciousness	85 (.27%)
Hypertension	85 (.27%)
Abdominal Pain Upper	84 (.27%)
Drug Effect Decreased	79 (.26%)
Rash	79 (.26%)
Hyperhidrosis	75 (.24%)
Weight Decreased	74 (.24%)
Arthralgia	73 (.24%)
Suicide Attempt	73 (.24%)
Product Substitution Issue	72 (.23%)
Abnormal Dreams	71 (.23%)
Multiple Drug Overdose Accidental	70 (.23%)
Drug Withdrawal Syndrome	69 (.22%)
Blood Glucose Increased	66 (.21%)
Dehydration	65 (.21%)
Wrong Technique In Drug Usage Proce...	64 (.21%)
Decreased Appetite	63 (.2%)
Tremor	63 (.2%)
Respiratory Depression	62 (.2%)
Urinary Tract Infection	62 (.2%)
Accidental Death	61 (.2%)
Product Quality Issue	61 (.2%)
Blood Pressure Decreased	60 (.19%)
Pyrexia	60 (.19%)
Gait Disturbance	59 (.19%)
Urticaria	57 (.18%)
Pulmonary Congestion	56 (.18%)
Condition Aggravated	55 (.18%)
Neck Pain	54 (.17%)
Road Traffic Accident	53 (.17%)
Vision Blurred	53 (.17%)
Weight Increased	53 (.17%)
Disorientation	51 (.16%)
Dysuria	51 (.16%)
Muscle Spasms	51 (.16%)
Withdrawal Syndrome	51 (.16%)
Delirium	50 (.16%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Hydrocodone, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Hydrocodone is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Hydrocodone

What are the most common Hydrocodone adverse events reported to the FDA?

Suicidal And Self-injurious Behavio...	3413 (11.02%)
Cardiac Arrhythmias	2519 (8.13%)
Medication Errors	1779 (5.74%)
Respiratory	1707 (5.51%)
Psychiatric	1647 (5.32%)
Neurological	1596 (5.15%)
Gastrointestinal Signs	1166 (3.76%)
Chemical Injury And Poisoning	899 (2.9%)
Therapeutic And Nontherapeutic Effe...	853 (2.75%)
Fatal Outcomes	690 (2.23%)
Injuries	563 (1.82%)
	Show More
Anxiety Disorders	455 (1.47%)
Infections - Pathogen Unspecified	398 (1.28%)
Epidermal And Dermal Conditions	378 (1.22%)
Musculoskeletal And Connective Tiss...	354 (1.14%)
Gastrointestinal Motility And Defec...	345 (1.11%)
Cardiac And Vascular Investigations	340 (1.1%)
Deliria	327 (1.06%)
Lifestyle Issues	322 (1.04%)
Sleep Disorders	314 (1.01%)
Hepatobiliary	311 (1%)
Mental Impairment	285 (.92%)
Metabolic, Nutritional And Blood Ga...	258 (.83%)
Depressed Mood Disorders	248 (.8%)
Headaches	248 (.8%)
Disturbances In Thinking	243 (.78%)
Lower Respiratory Tract Disorders	242 (.78%)
Hepatic And Hepatobiliary	232 (.75%)
Physical Examination Topics	224 (.72%)
Hematology Investigations	209 (.67%)
Muscle	205 (.66%)
Toxicology And Therapeutic Drug Mon...	200 (.65%)
Joint	181 (.58%)
Urinary Tract Signs	177 (.57%)
Water, Electrolyte And Mineral	176 (.57%)
Allergic Conditions	173 (.56%)
Decreased And Nonspecific Blood Pre...	171 (.55%)
Product Quality Issues	168 (.54%)
Appetite And General Nutritional	153 (.49%)
Electrolyte And Fluid Balance Condi...	150 (.48%)
Mood Disorders	143 (.46%)
Renal Disorders	127 (.41%)
Renal And Urinary Tract Investigati...	122 (.39%)
Procedural And Device Related Injur...	121 (.39%)
Skin Appendage Conditions	121 (.39%)
Personality Disorders	115 (.37%)
Seizures	112 (.36%)
Cardiac Disorder Signs	111 (.36%)
Vision	111 (.36%)
Bone And Joint Injuries	107 (.35%)
Movement Disorders	107 (.35%)
Central Nervous System Vascular	100 (.32%)
Ocular Neuromuscular	99 (.32%)
Enzyme	95 (.31%)
Bacterial Infectious	94 (.3%)
Vascular Hypertensive	92 (.3%)
Musculoskeletal And Connective Tiss...	87 (.28%)
Coronary Artery	85 (.27%)
Encephalopathies	83 (.27%)
Gastrointestinal Hemorrhages	80 (.26%)
Angiedema And Urticaria	78 (.25%)
Body Temperature Conditions	77 (.25%)
Myocardial	75 (.24%)
Dental And Gingival Conditions	74 (.24%)
Bronchial Disorders	62 (.2%)
Acid-base	59 (.19%)
Legal Issues	59 (.19%)
Lipid Analyses	56 (.18%)
Pulmonary Vascular	56 (.18%)
Upper Respiratory Tract Disorders	54 (.17%)
Viral Infectious	54 (.17%)
Oral Soft Tissue Conditions	52 (.17%)
Peripheral Neuropathies	51 (.16%)
Embolism And Thrombosis	50 (.16%)
Therapeutic Procedures And Supporti...	50 (.16%)
Psychiatric And Behavioural Symptom...	49 (.16%)
Coagulopathies And Bleeding Diathes...	48 (.15%)
Gastrointestinal Conditions	48 (.15%)
Gastrointestinal Stenosis And Obstr...	46 (.15%)
Inner Ear And Viiith Cranial Nerve	46 (.15%)
Arteriosclerosis, Stenosis, Vascula...	45 (.15%)
Glucose Metabolism Disorders	44 (.14%)
Salivary Gland Conditions	44 (.14%)
Administration Site Reactions	43 (.14%)
Bone Disorders	43 (.14%)
Increased Intracranial Pressure And...	41 (.13%)
Changes In Physical Activity	40 (.13%)
Heart Failures	39 (.13%)
Pleural	39 (.13%)
Anemias Nonhemolytic And Marrow Dep...	38 (.12%)
Ocular Infections, Irritations And ...	37 (.12%)
Demyelinating	34 (.11%)
Gallbladder	34 (.11%)
Vascular	34 (.11%)
Adrenal Gland	33 (.11%)
Sleep Disturbances	33 (.11%)
Exocrine Pancreas Conditions	32 (.1%)
Tissue	32 (.1%)
Hearing	31 (.1%)
Neuromuscular	31 (.1%)
Eye	30 (.1%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Hydrocodone, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Hydrocodone is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.